The value of erythromycin pleurodesis in the treatment of malignant pleural effusions

Journal of West China University of Medical Sciences

Volumn 28, Issue 4, 1997, Pages 437-439

  Xiaoyan, Tang ^a   Deyun, Cheng ^a  

^a FIRST AFFILIATED HOSPITAL   (China)

Author keywords

Erythromycin; Pleural effusion; Pleurodesis

Indexed keywords

ERYTHROMYCIN;

ARTICLE; DRUG EFFICACY; INFLAMMATION; PLEURA CAVITY; PLEURA EFFUSION; PLEURODESIS; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTI-BACTERIAL AGENTS; CARCINOMA, SQUAMOUS CELL; ERYTHROMYCIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; PLEURODESIS;

EID: 0031465805     PISSN: 02577712     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Miller JW, Hunter AM, Home NW. Intrapleural immunotherapy with corynebacterium parvum in recurrent malignant pleural effusions. Thorax, 1980; 35(11) : 856
2. Rubinson RM, Bolooki H. Intrapleural tetrcycline for control of malignant pleural effusion : a preliminary report. South Med J, 1972; 65(7) : 847
3. Aelony Y, King R, Boutin C. Thoracscopic talc poudrage pleurodesis for chronic recurrent pleural effusions. Ann Intern Med, 1991; 115(10) : 778
4. Rinaldo JE, Owens GR, Rogers RM. Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg, 1983; 85(4) : 523
5. Carvalho P, Knight LL, Olson RD, et al. Effects of erythromycin on the rabbit pleura : its potential role as a pleural sclerosant. Am J Respir Crit Care Med, 1995; 151(4) : 1228